BIOSIDUS

BIOSIDUS is an Argentine biotechnology company, distinguished as a pioneer and leader in the biosimilar sector within emerging markets. Established in 1983, the company has spent over two decades building a robust global operation dedicated to the research, development, production, and commercialization of high-quality biopharmaceuticals.

With its headquarters in Argentina, BIOSIDUS operates two industrial plants. The Almagro Plant in Buenos Aires focuses on R&D and the production of pharmaceutical active ingredients, equipped with capabilities in bacterial fermentation and large-scale cell culture. The Bernal Plant specializes in sterile operations, including aseptic filling, lyophilization, and packaging.

BIOSIDUS is entrenched within the Biotechnology, Manufacturing, and Pharmaceutical industries. Its last known investment round was a Private Equity Round on 07 June 2018, backed by ACON Investment and Humus Capital, signaling strong investor confidence in their global market strategy and scalable manufacturing infrastructure.